Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shepard

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Cancer Chemotherapy and Pharmacology|June 18, 2016
Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumorsDavid C Smith, John Powderly, James J Lee, et al.
Sarcoma|June 1, 2023
Accuracy of Time to Treatment Initiation Data in Musculoskeletal Soft Tissue SarcomaJoshua M Lawrenz, Jose F Vega, Jaiben George, et al.
Journal for Immunotherapy of Cancer|December 6, 2019
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumorsEzra E W Cohen, Michael J Pishvaian, Dale R Shepard, et al.
Journal of Neuro-Oncology|December 5, 2009
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiformeDavid M Peereboom, Dale R Shepard, Manmeet S Ahluwalia, et al.
Human Molecular Genetics|January 12, 2001
Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humorN Jacobson, M Andrews, A R Shepard, et al.
The Oncologist|June 8, 2019
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid TumorsM Dror Michaelson, Shilpa Gupta, Neeraj Agarwal, et al.
ESMO Open|April 9, 2025
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphomaU M Lauer, A Awada, S Postel-Vinay, et al.
Experimental Eye Research|March 19, 2013
Exon-level expression profiling of ocular tissuesAlex H Wagner, V Nikhil Anand, Wan-Heng Wang, et al.
Cancer Chemotherapy and Pharmacology|June 7, 2021
A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairmentMuhammad Wasif Saif, Carlos R Becerra, Marwan G Fakih, et al.
Journal of Clinical Microbiology|November 6, 2007
Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottlesJaneen R Shepard, Rachel M Addison, Barbara D Alexander, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|June 18, 2016
Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumorsDavid C Smith, John Powderly, James J Lee, et al.
Sarcoma|June 1, 2023
Accuracy of Time to Treatment Initiation Data in Musculoskeletal Soft Tissue SarcomaJoshua M Lawrenz, Jose F Vega, Jaiben George, et al.
Journal for Immunotherapy of Cancer|December 6, 2019
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumorsEzra E W Cohen, Michael J Pishvaian, Dale R Shepard, et al.
Journal of Neuro-Oncology|December 5, 2009
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiformeDavid M Peereboom, Dale R Shepard, Manmeet S Ahluwalia, et al.
Human Molecular Genetics|January 12, 2001
Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humorN Jacobson, M Andrews, A R Shepard, et al.
The Oncologist|June 8, 2019
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid TumorsM Dror Michaelson, Shilpa Gupta, Neeraj Agarwal, et al.
ESMO Open|April 9, 2025
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphomaU M Lauer, A Awada, S Postel-Vinay, et al.
Experimental Eye Research|March 19, 2013
Exon-level expression profiling of ocular tissuesAlex H Wagner, V Nikhil Anand, Wan-Heng Wang, et al.
Cancer Chemotherapy and Pharmacology|June 7, 2021
A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairmentMuhammad Wasif Saif, Carlos R Becerra, Marwan G Fakih, et al.
Journal of Clinical Microbiology|November 6, 2007
Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottlesJaneen R Shepard, Rachel M Addison, Barbara D Alexander, et al.
Pageof 13